Citius Pharmaceuticals Inc (CTXR)

Jun 05, 2025

Northern Trust Corp Sells 306,583 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World

Jun 05, 2025

Jun 04, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - mx.advfn.com

Jun 04, 2025

Jun 03, 2025

Citius Pharmaceuticals Issues $1M Promissory Note to Pagoda - TipRanks

Jun 03, 2025

May 29, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages - Defense World

May 29, 2025

May 27, 2025

Why Shares of SoundHound AI Are Soaring Today - The Globe and Mail

May 27, 2025

May 26, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Cut to Hold at Maxim Group - Defense World

May 26, 2025

May 23, 2025

Maxim Group Downgrades Citius Pharmaceuticals (CTXR) - MSN

May 23, 2025

May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

May 23, 2025

May 23, 2025

Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim Group - GuruFocus

May 23, 2025

May 23, 2025

Maxim Downgrades Citius Oncology to Hold From Buy - marketscreener.com

May 23, 2025

May 23, 2025

Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim | CTXR Stock News - GuruFocus

May 23, 2025

May 17, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Earns Buy Rating from D. Boral Capital - Defense World

May 17, 2025

May 16, 2025

Citius Pharmaceuticals (CTXR) Receives Continued "Buy" Rating fr - GuruFocus

May 16, 2025

May 16, 2025

Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments - TipRanks

May 16, 2025

May 15, 2025

Citius Pharmaceuticals (CTXR) Receives Continued "Buy" Rating from Analyst | CTXR Stock News - GuruFocus

May 15, 2025

May 14, 2025

Citius Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financi - GuruFocus

May 14, 2025

May 14, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 - GuruFocus

May 14, 2025

May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Laun - GuruFocus

May 14, 2025

May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Launch | CTXR Stock News - GuruFocus

May 14, 2025

May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025

May 14, 2025

Citius Pharmaceuticals Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025

May 11, 2025

Citius Pharmaceuticals (CTXR) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 09, 2025

Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR™ - Barchart.com

May 09, 2025

May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 05, 2025

May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - The Malaysian Reserve

May 05, 2025

May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | CTXR Stock News - GuruFocus

May 05, 2025

May 04, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Shares Sold by Geode Capital Management LLC - Defense World

May 04, 2025

May 04, 2025

3 Value Stocks with Mounting Challenges - The Globe and Mail

May 04, 2025

Apr 21, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.92 - Investing.com

Apr 21, 2025

Apr 21, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.92 By Investing.com - Investing.com Canada

Apr 21, 2025

Apr 12, 2025

Citius Pharmaceuticals (CTXR) Price Target Adjusted to $4 Amid S - GuruFocus

Apr 12, 2025

Apr 10, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.94 By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Citius Pharmaceuticals stock hits 52-week low at $0.94 - Investing.com Australia

Apr 10, 2025

Apr 04, 2025

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Longview News-Journal

Apr 04, 2025

Apr 03, 2025

Why Lululemon (LULU) Shares Are Getting Obliterated Today - The Globe and Mail

Apr 03, 2025

Apr 02, 2025

Citius Pharmaceuticals stock plummets on $2M registered direct offering of common stock - MSN

Apr 02, 2025

Apr 01, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.21 - Investing.com

Apr 01, 2025

Apr 01, 2025

Citius Pharmaceuticals stock hits 52-week low at $1.21 By Investing.com - Investing.com India

Apr 01, 2025

Apr 01, 2025

Citius Pharma secures $2 million in stock offering By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Citius Pharma secures $2 million in stock offering - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Citius Pharmaceuticals announces $2M registered direct offering of common stock - TipRanks

Apr 01, 2025

Mar 31, 2025

CTXR’s Stock Woes: Down -87.99% in 6 Months, Down -87.99% in Just 5 Days - investchronicle.com

Mar 31, 2025

Mar 28, 2025

IL-2s gain ground as US market heads for $4 billion by 2034 - The Pharma Letter

Mar 28, 2025

Mar 28, 2025

Analysts Expect Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) To Breakeven Soon - simplywall.st

Mar 28, 2025